These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1002350)

  • 1. The effect of propranolol, prindolol, practolol and verapamil versus placebo on exercise induced tachycardia in patients with ventricular preexcitation.
    Vrhovac B; Bakran I; Duraković Z; Gjurasin M; Francetić I; Mohacek I
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):132-43. PubMed ID: 1002350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia.
    Härtel G; Hartikainen M
    Eur J Cardiol; 1976 Mar; 4(1):87-90. PubMed ID: 1261584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exercise-induced tachyarrhythmic syncopes with sinus bradycardia and normal QT-interval at rest (author's transl)].
    Bernuth G; Lang D; Hofstetter R
    Z Kardiol; 1977 Feb; 66(2):55-60. PubMed ID: 842072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical results with verapamil in intravenous administration in the emergency therapy of cardiac arrhythmias].
    Amoroso A
    Minerva Med; 1975 May; 66(39):1904-13. PubMed ID: 1128830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
    Singh BN; Jewitt DE
    Drugs; 1974; 7(6):426-61. PubMed ID: 4153572
    [No Abstract]   [Full Text] [Related]  

  • 7. [Verapamil versus propranolol in stable effort angina. Randomized, crossed, double-blind study].
    Lesbre JP; Lalau JD; Jaubourg ML; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1988 Apr; 37(4):205-10. PubMed ID: 3285763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of propranolol on the Wolff-Parkinson-White syndrome].
    Demiroglu C; Göksel MF; Yavuz A; Oztürk M; Garan R
    Tip Fak Mecm; 1967; 30(2):333-6. PubMed ID: 5615227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data].
    Dolla E; Levy S; Cointe R; Moyal C; Bru P; Rossi P; Gérard R
    Arch Mal Coeur Vaiss; 1991 Jul; 84(7):917-21. PubMed ID: 1929709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous verapamil for paroxysmal supraventricular tachycardia in Wolff-Parkinson-White syndrome].
    Nissimov R
    Harefuah; 1982 Mar; 102(6):234-7. PubMed ID: 7160717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention by Propranolol of paroxysmal tachycardia of supraventricular origin. Long-term results].
    Bory M; Poggi L; d' Journo J; Serradimigni A; Audier M
    Arch Mal Coeur Vaiss; 1970 Feb; 63(2):174-81. PubMed ID: 4985972
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ergometric test in sympatheticotonia after administration of propranolol, pindolol, verapamil and oxazepam].
    Tkaczewski W; Goch JH; Wichan P; Kowalski J
    Pol Tyg Lek; 1980 Jun; 35(23):867-9. PubMed ID: 6997845
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical contribution in the treatment of paroxysmal tachycardia].
    Tassone F
    Minerva Med; 1974 Sep; 65(60):3140-6. PubMed ID: 4153900
    [No Abstract]   [Full Text] [Related]  

  • 15. Elective response to propranolol or verapamil in ischemia on effort.
    Levantesi D; Marraccini P; Michelassi C; Dalle Vacche M; L'Abbate A
    Can J Cardiol; 1989 Sep; 5(6):299-304. PubMed ID: 2676121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
    Penkov N; Penev A; Kaponov Kh
    Vutr Boles; 1984; 23(1):63-9. PubMed ID: 6730453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes of antianginal effects of verapamil in patients with stable effort angina. A medium term randomized double-blind placebo controlled trial.
    Acanfora D; De Caprio L; Di Palma A; Lirato C; Parlati S; Furgi G; Guerra N; Odierna L; Nicolino A; Rengo F
    G Ital Cardiol; 1993 May; 23(5):451-8. PubMed ID: 8339870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term management of exercise-induced myocardial ischemia. Diltiazem versus propranolol, a double-blind, crossover study.
    Romano M; di Maro T; Cotecchia MR; Carella G; de Arcangelis E; Clarizia M; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):551-4. PubMed ID: 3781675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of propranolol, practolol, and placebo on the clinical manifestations of thyrotoxicosis.
    Chapdelaine A; Coulombe R; LeLorier J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):308-12. PubMed ID: 794003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular pump function in effort angina. Influence of nitroglycerin, propranolol, verapamil, and coronary bypass surgery.
    Carlens P
    G Ital Cardiol; 1984 Oct; 14(10):809-16. PubMed ID: 6440828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.